津巴布韦HIV暴露与感染婴儿的肠道损伤及炎症标志物
在272名HIV感染婴儿(死亡者为病例、存活者为对照)、194名HIV暴露未感染(HEU)婴儿和197名HIV未暴露婴儿中,于6周龄和6月龄检测血浆I-FABP、sCD14、IL-6和CRP。HIV感染婴儿6周龄时sCD14和IL-6已升高并随时间增加,但无标志物与死亡或母乳传播相关;HEU婴儿炎症标志物高于未暴露婴儿直至至少6月龄。
要点
- HIV感染婴儿6周龄即出现sCD14、IL-6升高,6月龄时进一步升高
- 炎症标志物未与HIV感染婴儿死亡或母乳HIV传播风险相关
- HEU婴儿CRP在6周龄和6月龄均高于HIV未暴露婴儿
核心结论
- HIV感染婴儿在6周龄时炎症标志物已升高并随时间增加,但炎症标志物与死亡无关,与成人及年长儿童不同。
- HEU婴儿的炎症水平至少持续至6月龄高于HIV未暴露婴儿,可能与其不良健康结局相关。
研究设计与样本
- 在272名HIV感染婴儿中比较死亡病例与存活对照,并在194名HEU婴儿和197名HIV未暴露婴儿中检测生物标志物。
- 于6周龄和6月龄检测血浆I-FABP、sCD14、IL-6和CRP,采用逻辑回归估计死亡和产后HIV传播的多变量比值比。
主要发现
- 6周龄时HIV感染婴儿sCD14和IL-6高于HEU及HIV未暴露婴儿(P < .001),I-FABP较低(P < .001)。
- 6周龄时HEU婴儿CRP高于HIV未暴露婴儿(P = .02)。
- 6月龄时HIV感染婴儿sCD14、IL-6和CRP最高(P < .001),I-FABP仅边缘高于其他组(P = .07)。
- 6月龄时HEU婴儿CRP仍高于HIV未暴露婴儿(P = .04)。
- 无生物标志物与HIV感染婴儿死亡或HIV暴露婴儿母乳HIV传播几率相关。
临床怎么用
- 对HIV感染婴儿应关注炎症标志物升高,但其在此人群中不预示死亡,不能直接用作死亡风险分层工具。
- HEU婴儿炎症持续高于未暴露婴儿,提示需关注其长期健康结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Disease progression is rapid in human immunodeficiency virus (HIV)-infected infants. Whether intestinal damage and inflammation underlie mortality is unknown. METHODS: We measured plasma intestinal fatty acid binding protein (I-FABP), soluble CD14 (sCD14), interleukin 6 (IL-6), and C-reactive protein (CRP) at 6 weeks and 6 months of age in 272 HIV-infected infants who either died (cases) or survived (controls), and in 194 HIV-exposed uninfected (HEU) and 197 HIV-unexposed infants. We estimated multivariable odds ratios for mortality and postnatal HIV transmission for each biomarker using logistic regression. RESULTS: At 6 weeks, HIV-infected infants had higher sCD14 and IL-6 but lower I-FABP than HIV-exposed and HIV-unexposed infants (P < .001). CRP was higher in HIV-exposed than HIV-unexposed infants (P = .02). At 6 months, HIV-infected infants had highest sCD14, IL-6, and CRP concentrations (P < .001) and marginally higher I-FABP than other groups (P = .07). CRP remained higher in HIV-exposed vs HIV-unexposed infants (P = .04). No biomarker was associated with mortality in HIV-infected infants, or with odds of breast-milk HIV transmission in HIV-exposed infants. CONCLUSIONS: HIV-infected infants have elevated inflammatory markers by 6 weeks of age, which increase over time. In contrast to adults and older children, inflammatory biomarkers were not associated with mortality. HEU infants have higher inflammation than HIV-unexposed infants until at least 6 months, which may contribute to poor health outcomes.
引用
- Prendergast AJ, Chasekwa B, Rukobo S, et al. Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants. J Infect Dis. 2017. PMID: 28934432. doi:10.1093/infdis/jix367
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。